Biggest News Aggregation in the World
๐Ÿ“ฐ Looking Statement News

Page 75 - Looking Statement News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Looking Statement. Real-time updates on events, politics, business and more.

Northern Superior Resources Inc.: Northern Superior Resources Increases the Size of Previously Announced Non-Brokered Private Placement to C$5.0 Million, New Gold Inc. To Maintain Its 9.99% Ownership Stake

Not for distribution to United States newswire services or dissemination in the Unites StatesSUDBURY, ON / ACCESSWIRE / October 20, 2021 / Northern Superior Resources Inc. (the "Company" or "Northern Superior")
United States United Kingdom Lac Surprise Thomasf Morris Thomas Morris Company Or Northern Superior

Merck & Co., Inc.: Merck and Eisai Receive Positive EU CHMP Opinions for KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) in Two Different Types of Cancer

Positive Opinion Granted for Advanced Renal Cell Carcinoma Based on Significant Progression-Free Survival (PFS), Overall Survival (OS) and Objective Response Rate (ORR) Benefit Compared to Sunitinib
United States New Zealand Nikki Sullivan Peter Dannenbaum Melissa Moody Eisai Europe Ltd

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Merck and Eisai Receive Positive EU CHMP Opinions for KEYTRUDA® Plus LENVIMA® in Two Different Types of Cancer

Positive Opinion Granted for Advanced Renal Cell Carcinoma Based on Significant Progression-Free Survival Overall Survival and Objective Response Rate Benefit Compared to Sunitinib in CLEARKEYNOTE-581 Trial Positive Opinion Granted for Advanced Endometrial Carcinoma Based on Significant OS and PFS Benefit Compared to Chemotherapy in KEYNOTE-775Study 309 Trial Merck known as MSD outside the United States and Canada, ...
United States New Zealand Gregory Lubiniecki Nikki Sullivan Peter Dannenbaum Melissa Moody

Merck Receives Positive CHMP Opinion for VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) in

KENILWORTH, N.J.--(BUSINESS WIRE)--$MRK #MRK--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the European Medicines Agencyโ€™s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of VAXNEUVANCEโ„ข (Pneumococcal 15-valent Conjugate Vaccine) for ac...
United States Peter Dannenbaum Steve Wanczyk Melissa Moody European Commission Drug Administration

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science